Trial intelligence / Profile preview

Cyzact (ICX-PRO) in venous leg ulcers

NCT00232973Phase 3Unknown

Sponsor
Intercytex Group
Start
Jul 2005
Modality
Cell Therapies
Countries
3
01

Overview

A Phase 3 trial of Cyzact in venous leg ulcer (VLU), sponsored by Intercytex Group. Status: unknown.

02

Drugs

Cyzact
03

Conditions

venous leg ulcer (VLU)

Beyond the preview

Go deeper on NCT00232973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00232973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call